DeepHealth boosts ultrasound AI by integrating See-Mode team
See-Mode's commercially available AI-powered ultrasound detection, characterisation, and reporting solutions for thyroid and breast will be added to DeepHealth's suite of services. These technologies automatically detect and characterise thyroid nodules and breast lesions during ultrasound imaging, aiming to improve diagnostic accuracy and streamline clinical workflows through the generation of standardised reports.
The integration is set against the backdrop of rising global rates of thyroid cancer, which is among the fastest-growing cancer diagnoses worldwide. Alongside breast cancer, it remains a prevalent pathology, particularly impacting women.
Real-world deployment of See-Mode's FDA-cleared thyroid ultrasound AI at selected RadNet imaging centres has already shown operational benefits, with workflow efficiency improvements and enhancements to diagnostic accuracy. The company reported that the inclusion of See-Mode's automated detection and reporting has resulted in up to a 30 per cent reduction in scan time in the centres where it has been piloted.
Dr. Howard Berger, President and Chief Executive Officer of RadNet, commented, "Thyroid cancer is one of the fastest growing cancer diagnoses worldwide and, alongside breast cancer, is among the most common cancers affecting women. In the US alone, approximately 20 million ultrasound exams are performed annually for thyroid and breast combined. With ultrasound imaging inherently complex and user and radiologist-dependent, the opportunity to improve care through AI is significant."
Dr. Berger further noted, "Early deployment of See-Mode's FDA-approved thyroid ultrasound AI across a portion of our imaging centers has demonstrated up to a 30% reduction in scan time as a result of increased workflow efficiency from See-Mode's automated detection and reporting. With demand exceeding available appointment slots for many of our over 900 ultrasound units, the increase in capacity created by See-Mode's technology should improve our ability to drive better access and more revenue through RadNet's existing centers. Furthermore, there is already a reimbursement code that makes a portion of our approximately 250,000 annual thyroid ultrasounds eligible for additional reimbursement. We aim to expand these efficiencies to breast screening and other clinical areas in our more than two million annual ultrasound studies. These opportunities will also be sold and marketed by DeepHealth to third parties as we further commercialize the offerings."
See-Mode's AI technologies are currently cleared for commercial distribution in the United States, Canada, Australia, New Zealand, and Singapore. The acquisition supports DeepHealth's stated objective to strengthen its portfolio of AI-driven population health solutions and to address clinical and operational challenges in high-volume care settings.
Dr. Milad Mohammadzadeh, Co-Founder of See-Mode, added: "Ultrasound is complex, time-consuming, and high-volume—exactly where AI can make a difference. By joining RadNet and DeepHealth's combined access to real-world clinical data and expertise at an unprecedented scale, we have an extraordinary platform to build the future of ultrasound."
Echoing these remarks, Kees Wesdorp, President and Chief Executive Officer of RadNet's Digital Health division, said: "We are excited to integrate See-Mode's technology in thyroid and breast ultrasound into DeepHealth's comprehensive portfolio of AI-powered solutions for breast, lung, prostate, and brain, to address clinical and operational challenges in high-volume care settings. The technology and the team's expertise will be the basis for future AI-powered ultrasound solutions that will add to the growth engine of DeepHealth."
According to the information provided, DeepHealth currently operates more than 900 ultrasound units, conducting over two million ultrasound examinations each year. The company expects that the integration of See-Mode's technology will allow it to manage greater demand, improve workflow efficiencies, and address current appointment slot limitations.
Industry sources cited in the release note that in the United States alone, approximately 20 million ultrasound exams are performed each year for thyroid and breast combined. RadNet and DeepHealth aim to capitalise on these volumes by promoting their expanded suite of AI-driven solutions to both internal and third-party customers.
See-Mode's team and technology base in Singapore and Australia will join the DeepHealth operations, contributing their expertise to ongoing and future development of AI-driven ultrasound solutions. This collaboration is expected to facilitate the development of new applications in high-volume diagnostic imaging and to support improved access and outcomes across RadNet's network of imaging centres.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Otago Daily Times
3 days ago
- Otago Daily Times
Knox Podiatry: Caring for feet across Otago since 2013
At Knox Podiatry, we combine clinical excellence with genuine care. Whatever your needs, our team of six registered and professional podiatrists are here to help you put your best foot forward. We offer a wide range of services, including nail and skin treatments, nail surgery, musculoskeletal assessments, and treatment for foot and heel pain. At our main clinic in Mosgiel, we also house a fully equipped orthotics lab and use advanced 3D scanning technology to create custom orthotics for optimal comfort and support. We also provide: Nail cutting and ingrown toenail care Corn and callus removal Diabetic foot care and annual foot checks Gait and posture analysis Plantar fasciitis treatments Footwear advice with sizes up to US 15 All new patient appointments include a thorough foot health check – Think of it like a warrant of fitness for your feet – a check-up to keep everything running smoothly. Our Mosgiel clinic is purpose-built and modern, with light bright clinic rooms, and our front desk team is always happy to help with bookings and questions. All treatments use sterilised instruments to ensure infection control protocols. We are an ACC-approved provider and registered with Southern Cross, making your treatment easier to access and claim. We stock a wide range of orthotic-friendly shoes for women and men, along with soft top bamboo and cotton socks – perfect for sensitive or diabetic feet. We also carry a selection of high-quality foot creams, as well as gel products, bunion protectors, and toe separators to support your comfort and ongoing foot care at home. New to Knox Podiatry or haven't been in over two years? – Mention this article to receive 10% discount on your first appointment. For those based in Dunedin, why not take the short drive to Mosgiel? Parking is easy and free, and it's a great excuse to explore the local shops, grab lunch, and enjoy the charm of the main street.
NZ Herald
08-08-2025
- NZ Herald
Gentrified dripping: The rise of beef tallow in NZ kitchens
'I checked the expiry date before you arrived,' she said. And? 'October. It will be fine.' I guess she was right, because I am alive to type this tale. The beef tallow in my bag was for Mum. Growing up, she always kept a jar of dripping in the fridge door. Carefully saved from the roasting dish, the striations of rendered tallow and residual meat juice were testament to the fat-capped shoulders and legs of butchered beasts. We never ate this dripping on toast, because it was not the 1950s, and we had not spent the previous decade learning how to make the best of a bad world. But the fat from the last roast always crisped the spuds of the next one. 'Did you ever get to the bottom of that jar?' I asked my mum. I already knew the terrifying answer. I suspect, had olive oil not finally trickled south, she'd still be roasting spuds in that never-ending dripping. And now that dripping has been gentrified. Last year, purified beef fat began to infiltrate the skincare industry (aficionados swear by its moisturising properties). Meanwhile, in food stores and online, customers can buy 'premium wagyu beef tallow' and '100% organic NZ beef fat' and 'pure rendered grass fed beef tallow'. At Woolworth's, a 450g pottle of 'pure dripping' costs $6.50. But at the newly socially acceptable 'tallow' end of the market, prices are at least double and, frequently, three or four times higher. Yes, you read that correctly. In these Ozempic-approved times, when people pay $500 a month to NOT be fat, others are literally buying the stuff in jars. Beef tallow, as seen in the wild. Obviously, when Mitchells Nutrition asked if I'd like to sample their take on nature's high heat cooking oil made from 100% grass-fed and finished beef, I did not hesitate – who doesn't want to join the movement back to ancestral cooking and fry their chips with intention? Mitchells Nutrition is a local company founded by a former professional snowboarder whose first product was powdered bone broth. The business now sells everything from beef heart capsules to functional mushrooms. Its website claims tallow is high in vitamins A, D, E and K; the label on the back of the jar describes 'a primal approach to food prep' utilising the byproducts of the bone broth (seriously, don't get me started on what the marketing department has done to soup) cooking process. 'It's very ... yellow?' says my mother. A tablespoon of tallow the colour of creamed honey is scudding across the cast iron pan on her stove and dissolving into a pool of nostalgia. The kitchen smells vaguely of Sunday night, circa 1979. We are preparing to cook sausages, eggs and chips. The chips are in the air fryer (because it is not actually 1979) and the sausages are ready to go. But, first: I lower a slice of bread into the pan. It sucks up the melted fat and sizzles at the edges. Count slowly to 15. Flip the bread and count again. Lay it on a paper towel and sprinkle the surface with salt. 'Your grandma used to keep dripping in a big tin under the sink,' says my mum. 'Sometimes she made deep-fried scones for a treat ...' I cut the single slice into quarters and offer the plate to Mum. The bread is saturated in memory. Crisp and soft at the same time. Kim Knight is a senior journalist on the New Zealand Herald's lifestyle desk. She has a master's in gastronomy and was Canvas magazine's restaurant critic for five years.
Techday NZ
07-08-2025
- Techday NZ
DeepHealth gains FDA approval for remote scanning in ultrasound
DeepHealth has received FDA 510(k) clearance for its TechLive remote scanning solution, enabling centralised operations and supervision for MR, CT, PET/CT and, for the first time, Ultrasound procedures. Addressing staffing challenges The company's announcement comes as radiology workloads continue to rise, with the number of qualified technologists failing to keep pace. This disparity has contributed to staffing gaps and periods of MRI room closures, limiting access to complex scans and procedures for patients. DeepHealth aims to address these issues by equipping technologists with the ability to operate scanning equipment for multiple locations remotely. This model enables improved operational efficiency and extends the scope of experienced staff to more cases across different centres. Results from pilot study During a pilot deployment at 64 RadNet sites in the New York area, DeepHealth's TechLive solution contributed to a 42 percent decrease in MRI room closure hours during the second quarter of 2025, compared with the same period in 2024. According to DeepHealth, this resulted in more timely scans for patients and improved access to complex procedures. The company has also reported that, through remote expert involvement, TechLive contributed to an increase in the number of complex imaging procedures performed at these locations. The TechLive system currently connects over 300 RadNet MR, CT, PET/CT, and Ultrasound systems. By implementing real-time remote expertise, experienced senior sonographers and physicians can now guide on-site technologists through complex ultrasound cases - a modality noted for its reliance on operator skill and immediate decision-making. Company perspectives "TechLive represents a paradigm shift in how we approach imaging operations. By enabling real-time remote expertise, we are not only addressing today's staffing challenges, we are creating a foundation for more efficient, financially sustainable, and high-quality patient care across the broadest set of imaging modalities. This FDA clearance validates DeepHealth's vision of a connected imaging ecosystem that scales human expertise beyond physical boundaries," said Sham Sokka, PhD, Chief Operating and Technology Officer at DeepHealth. Operational impact TechLive has been introduced to streamline imaging operations, with specific attention to enhancing operational efficiency, extending operating hours for centres, and improving access to more complex diagnostic and therapeutic procedures. The solution's extension to Ultrasound marks the first industry application of remote scanning and supervision for this modality. By matching expert staff to complex cases in real time, DeepHealth seeks to increase patient throughput and maintain quality standards, while also helping care providers manage ongoing labour shortages and wage pressures in health services. Sector implications The increasing adoption of remote scanning solutions comes as healthcare providers face higher demand for complex imaging and persistent difficulty in recruiting qualified technologists. As radiology services evolve, solutions like TechLive are being considered as part of long-term strategies to maintain patient access and support a sustainable operational model. Follow us on: Share on:
